Loading...
Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?
BACKGROUND: The benefit of adjuvant immunotherapy after nephrectomy in renal cell carcinoma (RCC) is controversial. The present study aimed to examine the possible benefit of adjuvant immunotherapy in various clinical settings. METHODS: We retrospectively reviewed 436 patients with pT1-3N0-2M0 RCC w...
Saved in:
Published in: | PLoS One |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Public Library of Science
2017
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5328261/ https://ncbi.nlm.nih.gov/pubmed/28241027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0172341 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|